{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:18:41Z","timestamp":1791908321637,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-68\/2022-14\/200043"],"award-info":[{"award-number":["451-03-68\/2022-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The goal of research was to investigate the possible relations between serum concentrations of IL-6 and TGF-\u03b21, individual and clinical characteristics, and adverse effects of radiotherapy in patients with prostate cancer: acute and late genitourinary and gastrointestinal toxicity, and fatigue.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-nine patients with localized or locally advanced prostate cancer who were treated with radiotherapy were enrolled in this study. The acute radiotoxicity grades and fatigue levels were assessed during the radiotherapy and 1\u00a0month after the radiotherapy. Estimation of the late radiotoxicity was performed every three months in the first year, every four months in the second year, and then every six months. Serum levels of IL-6 and TGF-\u03b21 were determined before radiotherapy and after the 25<jats:sup>th<\/jats:sup> radiotherapy fraction by ELISA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The significant positive association between diabetes mellitus and changes in acute genitourinary toxicity grades during the radiotherapy was observed in prostate cancer patients. In addition, patients who were smokers had significantly higher maximum fatigue levels in comparison with patients who were non-smokers. The circulating IL-6 levels were significantly higher after the 25<jats:sup>th<\/jats:sup> radiotherapy fraction in comparison with levels determined before radiotherapy. The significant positive correlations between pretreatment TGF-\u03b21 levels and maximum genitourinary toxicity grades and between TGF-\u03b21 levels after the 25<jats:sup>th<\/jats:sup> fraction and genitourinary toxicity grades after the 25<jats:sup>th<\/jats:sup> fraction, were found. The pretreatment IL-6 concentrations and TGF-\u03b21 concentrations after the 25<jats:sup>th<\/jats:sup> fraction were positively correlated with maximum genitourinary toxicity grades. The IL-6 levels after the 25<jats:sup>th<\/jats:sup> fraction were positively associated with genitourinary toxicity grades after this fraction. The pretreatment IL-6 concentrations were significantly positively correlated with maximum fatigue scores. The significant positive correlation between IL-6 concentrations and fatigue scores after the 25<jats:sup>th<\/jats:sup> fraction was determined. The positive correlations between IL-6 and TGF-\u03b21 concentrations measured after the 25<jats:sup>th<\/jats:sup> fraction and maximum fatigue scores were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results suggest that serum levels of IL-6 and TGF-\u03b21 might influence the severity of acute genitourinary radiotoxicity and fatigue in patients with prostate cancer. Combining clinical parameters and circulating cytokine levels might be useful for the prediction of adverse reactions to radiotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10255-6","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T22:02:44Z","timestamp":1668204164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Circulating levels of IL-6 and TGF-\u03b21 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms"],"prefix":"10.1186","volume":"22","author":[{"given":"Katarina","family":"Kop\u010dali\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana Z.","family":"Mati\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Besu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Stankovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Bukumiri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana P.","family":"Stanojkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Stepanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Nikitovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"issue":"3","key":"10255_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"10255_CR2","volume-title":"Cancer Facts and Figures 2011","author":"American Cancer Society","year":"2011","unstructured":"American Cancer Society. Cancer Facts and Figures 2011. Atlanta: American Cancer Society; 2011."},{"issue":"9","key":"10255_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1470-2045(11)70162-0","volume":"12","author":"E Johansson","year":"2011","unstructured":"Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011;12(9):891\u20139.","journal-title":"Lancet Oncol"},{"issue":"8","key":"10255_CR4","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.7314\/APJCP.2013.14.8.4711","volume":"14","author":"HC Luo","year":"2013","unstructured":"Luo HC, Cheng HH, Lin GS, Fu ZC, Li DS. Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: long-term outcome of Chinese patients. Asian Pac J Cancer Prev. 2013;14(8):4711\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"10255_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/PPO.0b013e3181570121","volume":"13","author":"DF Penson","year":"2007","unstructured":"Penson DF. Quality of life after therapy for localized prostate cancer. Cancer J. 2007;13:318\u201326.","journal-title":"Cancer J"},{"issue":"1","key":"10255_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0360-3016(02)03866-X","volume":"55","author":"F Foroudi","year":"2003","unstructured":"Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys. 2003;55(1):51\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10255_CR7","doi-asserted-by":"crossref","unstructured":"Burnet NG, Johansen J, Turesson I, Nyman J, Peacock JH. Describing patients\u2019 normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2European Union Concerted Action Programme on the development of predictive tests of normal tissue response to radiation therapy. Int J Cancer. 1998;79:606\u201313.","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<606::AID-IJC9>3.0.CO;2-Y"},{"issue":"5","key":"10255_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE. Radiation therapy-associated toxicity: Etiology, management, and prevention. CA Cancer J Clin. 2021;71(5):437\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10255_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/gm268","volume":"3","author":"CM West","year":"2011","unstructured":"West CM, Barnett GC. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 2011;3(8):52.","journal-title":"Genome Med"},{"key":"10255_CR10","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1371\/journal.pmed.0030440","volume":"3","author":"AC Begg","year":"2006","unstructured":"Begg AC. Can the severity of normal tissue damage after radiation therapy be predicted? PLoS Med. 2006;3:e440.","journal-title":"PLoS Med"},{"key":"10255_CR11","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1200\/JCO.2014.58.5828","volume":"33","author":"D Wang","year":"2015","unstructured":"Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: Results of radiation therapy oncology group RTOG-0630 Trial. J Clin Oncol. 2015;33:2231\u20138.","journal-title":"J Clin Oncol"},{"issue":"9","key":"10255_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.clon.2016.04.041","volume":"28","author":"V Stankovic","year":"2016","unstructured":"Stankovic V, D\u017eamic Z, Pekmezovic T, Tepavcevic DK, Dozic M, Saric M, et al. Acute and Late Genitourinary Toxicity after 72 Gy of Conventionally Fractionated Conformal Radiotherapy for Localised Prostate Cancer: Impact of Individual and Clinical Parameters. Clin Oncol (R Coll Radiol). 2016;28(9):577\u201386.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10255_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.radonc.2012.03.012","volume":"103","author":"R Valdagni","year":"2012","unstructured":"Valdagni R, Vavassori V, Rancati T, Fellin G, Baccolini M, Bianchi C, et al. Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol. 2012;103:252\u20135.","journal-title":"Radiother Oncol."},{"key":"10255_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2013.09.028","volume":"110","author":"G Fellin","year":"2014","unstructured":"Fellin G, Rancati T, Fiorino C, Vavassori V, Antognoni P, Baccolini M, et al. Long term rectal function after high-dose prostate cancer radiotherapy: Results from a prospective cohort study. Radiother Oncol. 2014;110:272\u20137.","journal-title":"Radiother Oncol"},{"key":"10255_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijrobp.2011.06.1953","volume":"83","author":"C Fiorino","year":"2012","unstructured":"Fiorino C, Rancati T, Fellin G, Vavassori V, Cagna E, Casanova Borca V, et al. Late fecal incontinence after high-dose radiotherapy for prostate cancer: Better prediction using longitudinal definitions. Int J Radiat Oncol Biol Phys. 2012;83:38\u201345.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10255_CR16","doi-asserted-by":"crossref","unstructured":"Hunter GK, Reddy CA, Klein EA, Kupelian P, Angermeier K, Ulchaker J, et al. Long-term (10-Year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer. Prostate Cancer. 2012;2012:853487.","DOI":"10.1155\/2012\/853487"},{"key":"10255_CR17","doi-asserted-by":"crossref","unstructured":"Cella L, D\u2019Avino V, Liuzzi R, Conson M, Doria F, Faiella A, et al. Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer. Radiat Oncol. 2013;8:221.","DOI":"10.1186\/1748-717X-8-221"},{"issue":"6","key":"10255_CR18","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00520-013-1751-5","volume":"21","author":"B Langston","year":"2013","unstructured":"Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21(6):1761\u201371.","journal-title":"Support Care Cancer"},{"issue":"6","key":"10255_CR19","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/annonc\/mdr447","volume":"23","author":"DJ Storey","year":"2012","unstructured":"Storey DJ, McLaren DB, Atkinson MA, Butcher I, Frew LC, Smyth JF, Sharpe M. Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy. Ann Oncol. 2012;23(6):1542\u20139.","journal-title":"Ann Oncol"},{"key":"10255_CR20","doi-asserted-by":"crossref","unstructured":"Wang XS, Zhao F, Fisch MJ, O\u2019Mara AM, Cella D, Mendoza TR, Cleeland CS. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425\u201332.","DOI":"10.1002\/cncr.28434"},{"issue":"8","key":"10255_CR21","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00520-015-2763-0","volume":"23","author":"LN Saligan","year":"2015","unstructured":"Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, et al. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer. 2015;23(8):2461\u201378.","journal-title":"Support Care Cancer"},{"key":"10255_CR22","first-page":"2421","volume":"28","author":"X Provatopoulou","year":"2008","unstructured":"Provatopoulou X, Athanasiou E, Gounaris A. Predictive markers of radiation pneumonitis. Anticancer Res. 2008;28:2421\u201332.","journal-title":"Anticancer Res"},{"key":"10255_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2174\/13894501113149990198","volume":"14","author":"NH Ding","year":"2013","unstructured":"Ding NH, Li JJ, Sun LQ. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets. 2013;14:1347\u201356.","journal-title":"Curr Drug Targets"},{"issue":"17","key":"10255_CR24","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1158\/1078-0432.CCR-08-2584","volume":"15","author":"JE Bower","year":"2009","unstructured":"Bower JE, Ganz PA, Tao ML, Hu W, Belin TR, Sepah S, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15(17):5534\u201340.","journal-title":"Clin Cancer Res"},{"issue":"0","key":"10255_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2012.06.011","volume":"30 Suppl","author":"JE Bower","year":"2013","unstructured":"Bower JE, Lamkin DM. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun. 2013;30 Suppl(0):48\u201357.","journal-title":"Brain Behav Immun."},{"issue":"17","key":"10255_CR26","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1158\/1078-0432.CCR-09-0245","volume":"15","author":"E Christensen","year":"2009","unstructured":"Christensen E, Pintilie M, Evans KR, Lenarduzzi M, M\u00e9nard C, Catton CN, et al. Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity. Clin Cancer Res. 2009;15(17):5576\u201383.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10255_CR27","doi-asserted-by":"publisher","first-page":"19002","DOI":"10.1038\/s41598-020-75812-0","volume":"10","author":"TP Stanojkovi\u0107","year":"2020","unstructured":"Stanojkovi\u0107 TP, Mati\u0107 IZ, Petrovi\u0107 N, Stankovi\u0107 V, Kop\u010dali\u0107 K, Besu I, et al. Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients. Sci Rep. 2020;10(1):19002.","journal-title":"Sci Rep"},{"issue":"4","key":"10255_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","volume":"61","author":"ST Peeters","year":"2005","unstructured":"Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005;61(4):1019\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10255_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899\u2013905.","journal-title":"Urology"},{"issue":"5","key":"10255_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186\u201396.","journal-title":"Cancer"},{"issue":"5","key":"10255_CR31","first-page":"1224","volume":"21","author":"V Stankovic","year":"2016","unstructured":"Stankovic V, Nikitovic M, Pekmezovic T, Pekmezovic D, Kisic Tepavcevic D, Stefanovic Djuric A, Saric M. Toxicity of the lower gastrointestinal tract and its predictive factors after 72 Gy conventionally fractionated 3D conformal radiotherapy of localized prostate cancer. J BUON. 2016;21(5):1224\u201332.","journal-title":"J BUON"},{"key":"10255_CR32","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0022-5347(17)35937-2","volume":"150","author":"M Roach","year":"1993","unstructured":"Roach M. Equations for predicting the pathologic stage of men with localized prostate cancer using the preoperative prostate specific antigen (PSA) and Gleason score. J Urol. 1993;150:1923\u20134.","journal-title":"J Urol"},{"key":"10255_CR33","volume-title":"Prescribing, recording, and reporting photon beam therapy","author":"ICRU Report 50","year":"1993","unstructured":"ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements; 1993."},{"key":"10255_CR34","volume-title":"Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50)","author":"ICRU Report 62","year":"1999","unstructured":"ICRU Report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda, MD: International Commission on Radiation Units and Measurements; 1999."},{"key":"10255_CR35","doi-asserted-by":"crossref","unstructured":"International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Photon-Beam Intensity Modulated Radiation Therapy (IMRT). ICRU Report 83. Vol. 10, Journal of the ICRU. Oxford University Press; 2010.","DOI":"10.1093\/jicru\/ndq002"},{"issue":"3 Suppl","key":"10255_CR36","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10-19.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10255_CR37","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.urology.2013.01.047","volume":"81","author":"K Kalakota","year":"2013","unstructured":"Kalakota K, Liauw SL. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus. Urology. 2013;81(6):1196\u2013201.","journal-title":"Urology"},{"key":"10255_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ctro.2017.02.003","volume":"14","author":"A Alashkham","year":"2017","unstructured":"Alashkham A, Paterson C, Hubbard S, Nabi G. What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal study. Clin Transl Radiat Oncol. 2017;14:59\u201363.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10255_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4274\/uob.galenos.2020.1830","volume":"20","author":"M Da\u011fdelen","year":"2021","unstructured":"Da\u011fdelen M, Barlas C, Y\u0131ld\u0131r\u0131m C, \u00c7avdar Kara\u00e7am S, \u00d6ner Din\u00e7ba\u015f HF. Effect of Diabetes Mellitus and Metformin Usage on Treatment Outcomes and Side Effects on Prostate Cancer Treated with Radical Radiotherapy. Bull Urooncol. 2021;20(3):162\u20137.","journal-title":"Bull Urooncol"},{"issue":"1","key":"10255_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.radonc.2015.06.011","volume":"116","author":"N Yahya","year":"2015","unstructured":"Yahya N, Ebert MA, Bulsara M, Haworth A, Kennedy A, Joseph DJ, Denham JW. Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trial. Radiother Oncol. 2015;116(1):112\u20138.","journal-title":"Radiother Oncol"},{"issue":"7","key":"10255_CR41","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/01.CCM.0000170106.61978.D8","volume":"33","author":"M Turina","year":"2005","unstructured":"Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624\u201333.","journal-title":"Crit Care Med"},{"issue":"9","key":"10255_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1470-2045(03)01191-4","volume":"4","author":"HB Stone","year":"2003","unstructured":"Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529\u201336.","journal-title":"Lancet Oncol"},{"issue":"1","key":"10255_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","volume":"61","author":"L Bud\u00e4us","year":"2012","unstructured":"Bud\u00e4us L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, Wiegel T. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61(1):112\u201327.","journal-title":"Eur Urol"},{"issue":"1","key":"10255_CR44","doi-asserted-by":"publisher","first-page":"12286","DOI":"10.1038\/s41598-021-91510-x","volume":"11","author":"MZ Darabseh","year":"2021","unstructured":"Darabseh MZ, Maden-Wilkinson TM, Welbourne G, W\u00fcst RCI, Ahmed N, Aushah H, et al. Fourteen days of smoking cessation improves muscle fatigue resistance and reverses markers of systemic inflammation. Sci Rep. 2021;11(1):12286.","journal-title":"Sci Rep"},{"issue":"2","key":"10255_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000049774","volume":"40","author":"M Nuotio","year":"2001","unstructured":"Nuotio M, Jylh\u00e4 M, Koivisto AM, Tammela TL. Association of smoking with urgency in older people. Eur Urol. 2001;40(2):206\u201312.","journal-title":"Eur Urol"},{"issue":"3","key":"10255_CR46","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.prro.2017.09.002","volume":"8","author":"HH Chao","year":"2018","unstructured":"Chao HH, Doucette A, Raizen DM, Vapiwala N. Factors associated with fatigue in prostate cancer (PC) patients undergoing external beam radiation therapy (EBRT). Pract Radiat Oncol. 2018;8(3):e139\u201348.","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10255_CR47","first-page":"827","volume":"23","author":"RM Johnke","year":"2009","unstructured":"Johnke RM, Edwards JM, Evans MJ, Nangami GN, Bakken NT, Kilburn JM, et al. Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression. In Vivo. 2009;23(5):827\u201333.","journal-title":"In Vivo"},{"issue":"6","key":"10255_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1043-4666(03)00185-6","volume":"23","author":"CJ Kovacs","year":"2003","unstructured":"Kovacs CJ, Daly BM, Evans MJ, Johnke RM, Lee TK, Karlsson UL, et al. Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate. Cytokine. 2003;23(6):151\u201363.","journal-title":"Cytokine"},{"issue":"6","key":"10255_CR49","first-page":"3379","volume":"35","author":"N Tanji","year":"2015","unstructured":"Tanji N, Kikugawa T, Ochi T, Taguchi S, Sato H, Sato T, et al. Circulating Cytokine Levels in Patients with Prostate Cancer: Effects of Neoadjuvant Hormonal Therapy and External-beam Radiotherapy. Anticancer Res. 2015;35(6):3379\u201383.","journal-title":"Anticancer Res"},{"key":"10255_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/1099800413490228","volume":"16","author":"SR Dirksen","year":"2014","unstructured":"Dirksen SR, Kirschner KF, Belyea MJ. Association of symptoms and cytokines in prostate cancer patients receiving radiation treatment. Biol Res Nurs. 2014;16:250\u20137.","journal-title":"Biol Res Nurs"},{"issue":"1","key":"10255_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2015.12.015","volume":"118","author":"EB Holliday","year":"2016","unstructured":"Holliday EB, Dieckmann NF, McDonald TL, Hung AY, Thomas CR Jr, Wood LJ. Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study. Radiother Oncol. 2016;118(1):105\u201311.","journal-title":"Radiother Oncol"},{"issue":"3","key":"10255_CR52","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/NCC.0000000000000381","volume":"40","author":"LR Feng","year":"2017","unstructured":"Feng LR, Wolff BS, Lukkahatai N, Espina A, Saligan LN. Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy. Cancer Nurs. 2017;40(3):184\u201393.","journal-title":"Cancer Nurs"},{"issue":"11","key":"10255_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.21037\/atm.2019.05.31","volume":"7","author":"J Singh","year":"2019","unstructured":"Singh J, Sohal SS, Lim A, Duncan H, Thachil T, De Ieso P. Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings. Ann Transl Med. 2019;7(11):245.","journal-title":"Ann Transl Med"},{"issue":"2","key":"10255_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2015.01.045","volume":"368","author":"CN Sprung","year":"2015","unstructured":"Sprung CN, Forrester HB, Siva S, Martin OA. Immunological markers that predict radiation toxicity. Cancer Lett. 2015;368(2):191\u20137.","journal-title":"Cancer Lett"},{"key":"10255_CR55","doi-asserted-by":"publisher","first-page":"155108","DOI":"10.1016\/j.cyto.2020.155108","volume":"131","author":"J Singh","year":"2020","unstructured":"Singh J, Sohal SS, Ahuja K, Lim A, Duncan H, Thachil T, De Ieso P. Investigation of circulatory cytokines in patients undergoing intensity-modulated radiotherapy (IMRT) for adenocarcinoma of the prostate and association with acute RT-induced toxicity: a prospective clinical study. Cytokine. 2020;131:155108.","journal-title":"Cytokine"},{"issue":"5","key":"10255_CR56","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijrobp.2008.10.065","volume":"74","author":"L Zhao","year":"2009","unstructured":"Zhao L, Wang L, Ji W, Wang X, Zhu X, Hayman JA, et al. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys. 2009;74(5):1385\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10255_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<155::AID-IJC11>3.0.CO;2-S","volume":"84","author":"C Li","year":"1999","unstructured":"Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer. 1999;84(2):155\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"10255_CR58","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ijrobp.2013.08.045","volume":"87","author":"DL Boothe","year":"2013","unstructured":"Boothe DL, Coplowitz S, Greenwood E, Barney CL, Christos PJ, Parashar B, et al. Transforming growth factor \u03b2-1 (TGF-\u03b21) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: preliminary results of a prospective study. Int J Radiat Oncol Biol Phys. 2013;87(5):1030\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"10255_CR59","doi-asserted-by":"publisher","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","volume":"114","author":"JG Montoya","year":"2017","unstructured":"Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U S A. 2017;114(34):E7150\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10255_CR60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/pon.3422","volume":"23","author":"W Breitbart","year":"2014","unstructured":"Breitbart W, Rosenfeld B, Tobias K, Pessin H, Ku GY, Yuan J, Wolchok J. Depression, cytokines, and pancreatic cancer. Psychooncology. 2014;23(3):339\u201345.","journal-title":"Psychooncology"},{"issue":"5","key":"10255_CR61","doi-asserted-by":"publisher","first-page":"e0177620","DOI":"10.1371\/journal.pone.0177620","volume":"12","author":"\u00d8 Paulsen","year":"2017","unstructured":"Paulsen \u00d8, Laird B, Aass N, Lea T, Fayers P, Kaasa S, Klepstad P. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS ONE. 2017;12(5):e0177620.","journal-title":"PLoS ONE"},{"issue":"14","key":"10255_CR62","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1158\/1078-0432.CCR-18-1084","volume":"25","author":"H Yu","year":"2019","unstructured":"Yu H, Wu H, Wang W, Jolly S, Jin JY, Hu C, Kong FS. Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non-Small Cell Lung Cancer. Clin Cancer Res. 2019;25(14):4343\u201350.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10255-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T05:05:06Z","timestamp":1668315906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10255-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10255"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10255-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Institute for Oncology and Radiology of Serbia (approval No3348\/1\u201301). The details of the study were explained to the patients and informed consent forms were obtained from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1167"}}